GSDMD and neoplasm: To test this idea, we treated CD4+ T cells with tumor tissue supernatant during their in vitro activation, and found that cleavage of GSDMD and of caspase-8 were both weakened (Figure 6K), leading to reduced production of IL-2 (Supplemental Figure 6, E and F).